VeriMompalmitoyl sh-tripeptide-2 amide hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were identified for this ingredient; no peer‑reviewed reproductive or developmental toxicity reports located in PubMed. Cosmetic peptides such as palmitoylated tripeptides are reviewed in cosmetic ingredient databases (CosIng, PubChem) as cosmetic actives without reproductive hazard classifications, and EWG lists as a cosmetic peptide ingredient without reproductive hazard designation. Therefore default score 0 (no evidence of reproductive hazard).
Related ingredients
Frequently asked questions
- palmitoyl sh-tripeptide-2 amide hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were identified for this ingredient; no peer‑reviewed reproductive or developmental toxicity reports located in PubMed. Cosmetic peptides such as palmitoylated tripeptides are reviewed in cosmetic ingredient databases (CosIng, PubChem) as cosmetic actives without reproductive hazard classifications, and EWG lists as a cosmetic peptide ingredient without reproductive hazard designation. Therefore default score 0 (no evidence of reproductive hazard).
- palmitoyl sh-tripeptide-2 amide emzirirken güvenli mi?
- No data indicating reproductive or lactation-related toxicity, no harmonised classification, and no mechanistic data supporting transfer into breastmilk. Given likely negligible systemic absorption after topical use, exposure to breastfed infants is expected to be negligible.
- palmitoyl sh-tripeptide-2 amide bebek cildi için güvenli mi?
- No infant-specific toxicity data found (PubMed/CosIng). Hazard and mechanism default to 0 per lack of evidence. Exposure is increased by one level for infants versus adults because skin barrier immaturity and higher surface‑area‑to‑weight ratio can increase exposure; while topical palmitoylated peptides generally show low systemic absorption, measurable absorption cannot be excluded for infant skin, so e = 1.
- VeriMom palmitoyl sh-tripeptide-2 amide nasıl puanlıyor?
- VeriMom palmitoyl sh-tripeptide-2 amide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte palmitoyl sh-tripeptide-2 amide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.